Skip to content

Twist Bioscience Corporation TWST Reportable Segment — Cost of revenues

Similar metrics at other companies

Roivant Sciences logo
ROIVReportable Segment — Cost of revenues
$320K+56.1%
Neurocrine Biosciences logo
NBIXReportable Segment — Cost of revenues
$13.8M+50.0%
Forgent Power Solutions
 logo
FPSReportable Segment — Cost of Revenues
$247.51M+110%
Credo Technology Group Holding Ltd logo
CRDOReportable Segment — Cost of revenue
$138.94M+149%
Open Text logo
OTEXReportable Segment — Adjusted cost of revenues
$298.99M-2.1%
Guardant Health logo
GHReportable Segment — Cost of revenue
$101.56M+40.7%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept twst:CostOfRevenueExcludingDepreciationAmortizationAndShareBasedCompensationExpense.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's reportable segment — cost of revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's reportable segment — cost of revenues?
Twist Bioscience Corporation (TWST) reported reportable segment — cost of revenues of $47.4M in Q1 2026.
How has Twist Bioscience Corporation's reportable segment — cost of revenues changed year-over-year?
Twist Bioscience Corporation's reportable segment — cost of revenues increased by 17.4% year-over-year, from $40.37M to $47.4M.
What does reportable segment — cost of revenues mean?
Includes the direct costs attributable to the production of goods or the delivery of services provided by the reportable segment. Monitoring this metric helps assess the direct manufacturing efficiency and the impact of input costs on the segment's gross margin.